Probable osteosarcoma risk after prolonged teriparatide treatment: comment on the article by Saag et al

Basit Öğe Kaydı
dc.authoridZateri, Coskun/0000-0002-7948-5383
dc.contributor.authorTastekin, Nurettin
dc.contributor.authorZateri, Coskun
dc.date.accessioned2025-01-27T20:34:34Z
dc.date.available2025-01-27T20:34:34Z
dc.date.issued2010
dc.departmentÇanakkale Onsekiz Mart Üniversitesi
dc.description.abstract[Anstract Not Available]
dc.identifier.doi10.1002/art.27427
dc.identifier.endpage1837
dc.identifier.issn0004-3591
dc.identifier.issue6
dc.identifier.pmid20191586
dc.identifier.startpage1837
dc.identifier.urihttps://doi.org/10.1002/art.27427
dc.identifier.urihttps://hdl.handle.net/20.500.12428/23357
dc.identifier.volume62
dc.identifier.wosWOS:000279432500036
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherWiley-Liss
dc.relation.ispartofArthritis and Rheumatism
dc.relation.publicationcategoryDiğer
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WoS_20250125
dc.subjectGlucocorticoid-Induced Osteoporosis
dc.subjectAlendronate
dc.subjectBone
dc.titleProbable osteosarcoma risk after prolonged teriparatide treatment: comment on the article by Saag et al
dc.typeLetter

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu